DataMeds AI, Inc. SEC filings MEDS

DataMeds AI, Inc. has 176 filings in SEC EDGAR's recent list, going back to Jul 22, 2024. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (agreement ended, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
PRE 14C Filing Oct 9, 2026 Oct 9, 2026
PRE 14C Filing Aug 31, 2026 Aug 31, 2026
PRE 14A Preliminary proxy statement Jun 18, 2026 Jun 18, 2026
DEF 14A Proxy statement May 4, 2026 May 4, 2026
PRE 14A Preliminary proxy statement Apr 24, 2026 Apr 24, 2026
DEF 14C Information statement Apr 3, 2026 Apr 3, 2026
PRE 14C Filing Mar 25, 2026 Mar 24, 2026
DEF 14C Information statement Oct 31, 2025 Oct 31, 2025
PRE 14C Filing Oct 21, 2025 Oct 21, 2025

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
MEDS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tampa, FL
SEC filer status
, Emerging growth company
SEC CIK
2030763
Former names
Wellgistics Health, Inc. (until Jul 21, 2026); Danam Health, Inc (until Sep 27, 2024)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.